Contact Us: 01282 426380
KM Financial Solutions | Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 bln euros
14792
post-template-default,single,single-post,postid-14792,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 bln euros

16 Apr Sanofi in talks to sell generics arm Zentiva to Advent for 1.9 bln euros

Posted at 06:41h in News by
0 Likes
PARIS, April 17 (Reuters) – French healthcare group Sanofi
has started exclusive talks with private equity firm
Advent International over selling its Zentiva European generics
drugs arm to Advent for 1.9 billion euros ($2.4 billion), the
companies said.

No Comments

Sorry, the comment form is closed at this time.